Evidence map›Paper›PMID 33403591›Full record

ArticleJournal of molecular neuroscience : MN2021

Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats.

Lyubka Tancheva, Maria Lazarova, Luciano Saso, Reni Kalfin, Miroslava Stefanova, Diamara Uzunova, Atanas G Atanasov

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

Lyubka TanchevaWeston Visiting Professor of Weizmann Institute of Science, 234 Herzl Str, 76100, Rehovot, Israel.
Maria LazarovaInstitute of Neurobiology, Bulgarian Academy of Sciences, Acad. G, Bonchev Str., bl. 23, Sofia, 1113, Bulgaria.
Luciano SasoDepartment of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University, P.le Aldo Moro 5, 00185, Rome, Italy.
Reni KalfinInstitute of Neurobiology, Bulgarian Academy of Sciences, Acad. G, Bonchev Str., bl. 23, Sofia, 1113, Bulgaria. reni_kalfin@abv.bg.ORCID http://orcid.org/0000-0002-7764-3640
Miroslava StefanovaInstitute of Neurobiology, Bulgarian Academy of Sciences, Acad. G, Bonchev Str., bl. 23, Sofia, 1113, Bulgaria.
Diamara UzunovaInstitute of Neurobiology, Bulgarian Academy of Sciences, Acad. G, Bonchev Str., bl. 23, Sofia, 1113, Bulgaria.
Atanas G AtanasovInstitute of Neurobiology, Bulgarian Academy of Sciences, Acad. G, Bonchev Str., bl. 23, Sofia, 1113, Bulgaria.
Bulgarian Academy of Sciences · BGUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous evidence has shown a link between neurodegenerative diseases, including Parkinson's disease (PD), and melatonin. The data in the literature about the impact of the hormone under different experimental PD conditions are quite controversial, and its effect on memory impairment in the disease is very poorly explored. The current research was aimed at investigating the role of melatonin pretreatment on memory and motor behavior in healthy rats and those with the partial 6-hydroxydopamine (6-OHDA) model of PD. All rodents were pretreated with melatonin (20 mg/kg, intraperitoneally) for 5 days. At 24 h and 7 days after the first treatment for healthy rats, and at the second and third week post-lesion for those with PD, the animals were tested behaviorally (apomorphine-induced rotations, rotarod, and passive avoidance tests). The neurochemical levels of dopamine (DA), acetylcholine (ACh), noradrenaline (NA), and serotonin (Sero) in the brain were also determined. The results showed that in healthy animals, melatonin pretreatment had amnestic and motor-suppressive effects and did not change the levels of measured brain neurotransmitters. In animals with PD, melatonin pretreatment exerted a neuroprotective effect, manifested as a significantly decreased number of apomorphine-induced rotations, reduced number of falls in the rotarod test, and improved memory performance. The brain DA and ACh concentrations in the same animals were restored to the control levels, and those of NA and Sero did not change. Our results demonstrate a beneficial effect of melatonin on memory and motor disturbance in 6-OHDA-lesioned rats.

Indexed as

MemoryMovementAnimalsAntiparkinson AgentsBrainMaleMelatoninNeurotransmitter AgentsOxidopamineParkinson DiseaseRatsRats, WistarAntiparkinson AgentsMelatoninNeurotransmitter AgentsOxidopamine6-OHDABeneficial effectMelatoninMemoryParkinson’s disease

Identifiers

PMID33403591
OpenAlexW3118309025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.